Sort
261,768 grants matching “gene therapy”
Understanding and Mimicking TCR Recognition with Therapeutic Monoclonal Antibodies.
$1,062,000David A Scheinberg · Sloan-Kettering Inst Can Research · R35 · FY2025 · CA
Role of the Epitranscriptome in Cancer
$1,062,000Richard I. Gregory · Boston Children'S Hospital · R35 · FY2020 · CA
Towards targeting the lymphoma microenvironment
$1,062,000Hans-Guido Wendel · Sloan-Kettering Inst Can Research · R35 · FY2021 · CA
Towards targeting the lymphoma microenvironment
$1,062,000Hans-Guido Wendel · Sloan-Kettering Inst Can Research · R35 · FY2025 · CA
Role of the Epitranscriptome in Cancer
$1,062,000Richard I. Gregory · Boston Children'S Hospital · R35 · FY2021 · CA
Transgenic Core Facility
$1,061,979Deborah Swing · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA
GENE THERAPY FOR METABOLIC DISORDERS
$1,061,927University Of Minnesota Twin Cities · P01 · FY2001 · HD
Stem Cells And The Origins of Barrett's Esophagus
$1,061,716Timothy Cragin Wang · Columbia University Health Sciences · U54 · FY2013 · CA
Clinical Evaluation of a Personalized Vaccine Immunotherapy in Combination with Checkpoint Inhibitors for Triple Negative Breast Cancer
$1,061,403Christopher D Pack · Metaclipse Therapeutics Corporation · R44 · FY2021 · CA
Identification of radiosensitizers for prostate cancer
$1,061,377Travis Stracker · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Alleviation of ER stress as a translational strategy to curb ocular viral infections
$1,061,330Deepak Shukla · University Of Illinois At Chicago · R24 · FY2023 · EY
TARGETING PCD FOR CANCER THERAPY
$1,061,323University Of Michigan At Ann Arbor · P01 · FY2001 · CA
Mito-Targeted AAV to treat Leber Hereditary Optic Neuropathy caused by ND4 mutations
$1,061,273Vittorio Porciatti · University Of Miami School Of Medicine · R24 · FY2022 · EY
Neuroengineering a Robust Vocal Learning Phenotype in Mice as a Model for Treating Communication Disorders
$1,061,246Erich D Jarvis · Rockefeller University · R01 · FY2021 · DC
Epigenomics of T cells and innate immune cells in human asthma
$1,061,129Anjana Rao · La Jolla Institute For Immunology · R01 · FY2013 · HL
University of California and UT Southwestern D-PDTC
$1,061,087Luis Guillermo Carvajal Carmona · University Of California At Davis · U54 · FY2023 · CA
GENE THERAPY FOR METABOLIC DISORDERS
$1,061,040University Of Minnesota Twin Cities · P01 · FY2000 · HD
PROgression of Tuberculosis infECTion in young children living with and without HIV: the PROTECT study
$1,061,038Adithya Cattamanchi · University Of California-Irvine · R01 · FY2025 · AI
A Patient-Centric Approach to Advance Functional Precision Oncology
$1,060,954Christopher J Kemp · Fred Hutchinson Cancer Center · U01 · FY2025 · CA
Role of the innate immune defenses in viral infections
$1,060,903Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2016 · DK
Center for Gene Therapy of Cystic Firbosis
$1,060,875John F Engelhardt · University Of Iowa · P30 · FY2013 · DK
Dysregulation of Protein Synthesis in Fragile X Syndrome
$1,060,826Carolyn B. Smith · National Institute Of Mental Health · ZIA · FY2014 · MH
Targeting intratumor heterogeneity in breast cancer
$1,060,812Kornelia Polyak · Dana-Farber Cancer Inst · R35 · FY2022 · CA
Targeting intratumor heterogeneity in breast cancer
$1,060,812Kornelia Polyak · Dana-Farber Cancer Inst · R35 · FY2025 · CA
Novel MAP Kinase Pathway Inhibitors to Treat Pancreatic Ductal AdenoCarcinoma
$1,060,799Peter Qinhua Huang · Zeno Management, Inc · R44 · FY2018 · CA